Sutent Mechanism Gallery Mode [2022] Sutent Mechanism Gallery Mode [2022]

Sutent Mechanism

Nov. 28, 2024

Molecular basis for sunitinib efficacy and future clinical development | Nature Reviews Drug Discovery The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma | British Journal of Cancer Mechanisms of action of sunitinib (from Rini et al., with the... | Download Scientific Diagram Sutent Mechanism


Link 1 | Link 2 | Link 3 | Link 4 | Link 5 | Link 6 |